Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells

  • Authors:
    • Carolina Alonso-González
    • Javier Menéndez-Menéndez
    • Alicia González-González
    • Alicia González
    • Samuel Cos
    • Carlos Martínez-Campa
  • View Affiliations

  • Published online on: November 28, 2017     https://doi.org/10.3892/ijo.2017.4213
  • Pages:560-570
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Results from clinical trials and multiple in vivo and in vitro studies point to melatonin as a promising adjuvant molecule with many beneficial effects when concomitantly administered with chemotherapy. Melatonin palliates side‑effects and enhances the efficacy of chemotherapeutic agents. However, the mechanisms through which melatonin regulates molecular changes induced by chemotherapeutic agents remain largely unknown. In this study, we demonstrated that melatonin enhanced the anti-proliferative and apoptotic responses to low doses of docetaxel in breast cancer cells. Importantly, these effects were more potent when melatonin was added prior to docetaxel. Treatment with 1 µM docetaxel (equivalent to the therapeutic dosage) induced changes in gene expression profiles and melatonin modulated these changes. Specifically, docetaxel downregulated TP53, cyclin-dependent kinase inhibitor 1A (CDKN1A) and cadherin 13 (CDH13), and upregulated mucin 1 (MUC1), GATA binding protein 3 (GATA3) and c-MYC, whereas melatonin counteracted these effects. Melatonin further stimulated the expression of the pro-apoptotic BAD and BAX genes, and enhanced the inhibition of the anti-apoptotic gene BCL-2 induced by docetaxel. The findings of this study suggest that melatonin is a molecule with potential for use as an adjuvant in cancer chemotherapy, which may have implications for designing clinical trials using chemotherapeutic drugs in combination with melatonin.

Related Articles

Journal Cover

February 2018
Volume 52 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Alonso-González, C., Menéndez-Menéndez, J., González-González, A., González, A., Cos, S., & Martínez-Campa, C. (2018). Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells. International Journal of Oncology, 52, 560-570. https://doi.org/10.3892/ijo.2017.4213
MLA
Alonso-González, C., Menéndez-Menéndez, J., González-González, A., González, A., Cos, S., Martínez-Campa, C."Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells". International Journal of Oncology 52.2 (2018): 560-570.
Chicago
Alonso-González, C., Menéndez-Menéndez, J., González-González, A., González, A., Cos, S., Martínez-Campa, C."Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells". International Journal of Oncology 52, no. 2 (2018): 560-570. https://doi.org/10.3892/ijo.2017.4213